Emerging Markets: May Monthly Commentary

2 minutes read timeA positive relative performance of 0.4% in March has led us to finish the first quarter of 2024 with an outperformance of 2.3% against the MSCI Emerging Markets index.

Emerging Markets Income: April Monthly Commentary

2 minutes read timeApril proved to be the first month in a while that we saw some meaningful rotation in the geographic performance of the fund. Our weakest markets were Taiwan, Mexico and Brazil, largely triggered by resurgent concerns over the path of US interest rates. Our top performers were in China/Hong Kong, Chile and Greece.

Emerging Markets: April Monthly Commentary

2 minutes read timeDuring April the fund underperformed the MSCI Emerging Markets index by 1.8%. The largest relative detractor was China, in particular due to some weak market closes on US listed ADRs at the end of the month.

Emerging Markets: March Monthly Commentary

3 minutes read timeA positive relative performance of 0.4% in March has led us to finish the first quarter of 2024 with an outperformance of 2.3% against the MSCI Emerging Markets index.

Emerging Markets: January Monthly Commentary

2 minutes read timeEmerging Market equities surrendered all of December’s hard-won gains, led on the downside once again by Chinese markets. During the month, the largest relative contribution came from our positions in Korea, followed by China and Greece.

Emerging Markets Income: December Monthly Commentary

3 minutes read timeOver the month the fund gained 4.5% and finished the year at an all-time high. This brought the quarterly return to 6.2% and the full year total return to 19.3%. The fourth quarter distribution of £0.103238 was lower than last year partly due to our Korean companies that moved ex-div dates into the first quarter […]